Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1999
05/06/1999EP0912556A1 Indoline derivatives useful as 5-ht-2c receptor antagonists
05/06/1999EP0912555A1 Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders
05/06/1999EP0912554A1 Indoline derivatives useful as 5-ht-2c receptor antagonists
05/06/1999EP0912553A1 BENZO[g]QUINOLINE DERIVATIVES
05/06/1999EP0912552A1 2,4-diaminopyrimidine derivates as dopamine d4 receptor antagonists
05/06/1999EP0912551A1 Somatostatin agonists and antagonists
05/06/1999EP0912549A1 Compounds and methods for providing pharmacologically active preparations and uses thereof
05/06/1999EP0912545A1 Hydroxamic acid based collagenase inhibitors
05/06/1999EP0912543A1 Crystalline (-)-3r,4r-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-[4- 2-(pyrrolidin-1-yl)ethoxy]phenyl chromane, hydrogen fumarate
05/06/1999EP0912542A1 Oxocoumarin and barbituric acid derivates, their preparation and their use as ligand inhibitors of a corticotropin-releasing factor (crf) and/or a crf-binding protein complex
05/06/1999EP0912539A1 Heteroaromatic pentadienoic acid derivatives useful as inhibitors of bone resorption
05/06/1999EP0912535A1 Conjugates of cis-docosahexaenoic acid and paclitaxel
05/06/1999EP0912534A1 Muscarinic antagonists
05/06/1999EP0912533A1 Alkylaminobenzothiazole and -benzoxazole derivatives
05/06/1999EP0912526A1 Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof
05/06/1999EP0912523A1 Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
05/06/1999EP0912521A1 Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
05/06/1999EP0912520A1 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
05/06/1999EP0912519A1 Quinoline sulfonamides as tnf inhibitors and as pde-iv inhibitors
05/06/1999EP0912518A1 Substituted pyridines as selective cyclooxygenase-2 inhibitors
05/06/1999EP0912516A1 Anticonvulsant pyridinyl benzamide derivatives
05/06/1999EP0912515A1 1,4-di-sustituted piperidines as muscarinic antagonists
05/06/1999EP0912513A1 Fibrinogen receptor antagonist prodrugs
05/06/1999EP0912512A1 Sulphonamide derivatives and their use in the treatment of cns disorders
05/06/1999EP0912511A1 5-indolyl-2,4-pentadienoic acid derivatives useful as inhibitors of bone resorption
05/06/1999EP0912509A1 Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
05/06/1999EP0912507A1 Cyclopentan(en)oic acid, 2-alkenyl derivatives as therapeutic agents in the treatment of ocular hypertension
05/06/1999EP0912505A1 Il-8 receptor antagonists
05/06/1999EP0912498A1 4(4-oxocyclohexyl) benzamides as intermediate products for medicaments
05/06/1999EP0912496A1 Inhibition of matrix metalloproteases by acetylene containing compounds
05/06/1999EP0912494A1 Coumpounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
05/06/1999EP0912491A1 Polyol succinates and their pharmaceutical formulation
05/06/1999EP0912487A1 Substituted oxobutyric acids as matrix metalloprotease inhibitors
05/06/1999EP0912198A1 Immunoliposomes that optimize internalization into target cells
05/06/1999EP0912196A1 Use of a thexaphyrin in the preparation of a medicament for use with a chemotherapeutic agent in cancer chemosensitization
05/06/1999EP0912191A1 Vegetable extract, method for preparation thereof and its applications in human and veterinary medicine
05/06/1999EP0912187A2 Compositions and methods for the prevention and treatment of atherosclerosis and reperfusion injury with magnesium salts
05/06/1999EP0912186A1 Progestogen-anti-progestogen regimens
05/06/1999EP0912185A1 Novel pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
05/06/1999EP0912184A1 Use of k-252a derivative for the treatment of peripheral or central nerve disorders, and cytokine overproduction
05/06/1999EP0912183A1 Heterocyclic compounds
05/06/1999EP0912182A1 Fibrinogen receptor antagonist prodrugs
05/06/1999EP0912181A1 Appetite suppression
05/06/1999EP0912180A1 Heterocyclic compounds with thrombolytic activity and their use for treating thrombosis
05/06/1999EP0912179A1 Deoxynojirimycin derivatives and their uses as glucosylceramidase inhibitors
05/06/1999EP0912178A1 Methods of treating hypertension
05/06/1999EP0912177A1 Use of flupirtine to prevent cell damage by apoptosis and necrosis
05/06/1999EP0912176A1 Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression
05/06/1999EP0912175A1 Fibrinogen receptor antagonists
05/06/1999EP0912174A1 Alteration of circadian rhythmicity with a tachykinin antagonist
05/06/1999EP0912173A1 Use of a tachykinin antagonist for the manufacture of a medicament for the treatment of emesis
05/06/1999EP0912172A1 Combination of cis-4-hydroxy-l-proline and n-methyl-cis-4-hydroxy-l-proline for use as a therapeutic agent, in particular in cancer treatment
05/06/1999EP0912171A1 Benzamide treatment of dementia associated with aids virus (hiv-1) infection
05/06/1999EP0912170A1 Hiv protease inhibitors useful for the treatment of aids
05/06/1999EP0912169A2 $g(b)-LACTAM GRANULES FREE OF ORGANIC SOLVENTS
05/06/1999EP0912168A2 Ephedrine in granular form with a high active substance content
05/06/1999EP0912167A1 Granulates of hexahydropyrazine derivatives which can be administered orally
05/06/1999EP0912157A1 Isolated arachidonic acid-binding heteromer and its use in cosmetics and pharmaceutics
05/06/1999EP0912110A1 Improvements in or relating to compositions containing creatine
05/06/1999EP0912106A1 Agent for increasing the production of/in breeding and production mammals
05/06/1999EP0912097A1 Antimicrobial peroxidase compositions
05/06/1999EP0912091A1 Use of gaba uptake inhibitors as anti-tussive agents
05/06/1999EP0912086A1 Regulation of alzheimer's disease related proteins and uses thereof
05/06/1999EP0883596A4 Fluorinated propranolol and related methods
05/06/1999EP0794953B1 Quinazoline derivatives
05/06/1999EP0772604B1 Triazole compounds and their use as dopamine-d3-ligands
05/06/1999EP0750607B1 2-(aminoalkoxy)phenylalkylamines with antiinflammatory activity
05/06/1999EP0737187B1 Benzoxazine derivatives, methods for obtaining same and their use as drugs
05/06/1999EP0727981B1 Antiperspirants and method of applying antiperspirant using a shaped article
05/06/1999EP0721457B1 2',5'-OLIGOADENYLATE-2',3'-CYCLOPHOSPHATES and 2',5'-OLIGOADENYLATES with antipapilloma virus activity
05/06/1999EP0688320B1 Tricyclic benzodiazepins, their use and preparation
05/06/1999EP0688315B1 Pyrrolidine and oxazolidine derivatives, their preparation and their use as inhibitors of thrombocyte aggregation
05/06/1999EP0684818B1 Method of reversing resistance of hiv-1 strains to zidovudine
05/06/1999EP0684242B1 Isoxazolidinedione derivative and use thereof
05/06/1999EP0680333B1 Prevention and treatment of cytomegalovirus using aminopeptidase
05/06/1999EP0677990B1 Compositions and uses thereof
05/06/1999EP0634171B1 Pharmaceutical composition for treating cerebral thrombosis
05/06/1999EP0623114B1 Phenyl imidazolidinone derivatives, process for their preparation and their use as 5ht3 receptor antagonists
05/06/1999EP0618796B1 Alleviating or prevention of migraine headache onset with mast cell degranulation blocking agents
05/06/1999EP0589034B1 Method for making 3-alpha-hydroxy,3-beta-substituted-pregnanes
05/06/1999EP0582581B1 1-SUBSTITUTED, 2-SUBSTITUTED 1H-IMIDAZO[4,5-c]QUINOLIN-4-AMINES
05/06/1999EP0574571B1 Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation
05/06/1999EP0570519B1 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
05/06/1999EP0550702B1 METHODS FOR PREPARATION AND USE OF 1$g(a),24-DIHYDROXY VITAMIN D 2?
05/06/1999EP0541692B1 Herpes simplex virus vp16 vaccines
05/06/1999DE19812652A1 Use of L-citrulline
05/06/1999DE19748763A1 Verwendung von Vasopressin-Antagonisten Use of vasopressin antagonists
05/06/1999DE19748659A1 Aminophosphoniumgruppen enthaltende vernetzte Copolymere für medizinische Verwendungen Aminophosphoniumgruppen containing crosslinked copolymers for medical uses
05/06/1999DE19748195A1 Disaccharidderivate zur Behandlung von Hyperglykämien Disaccharide derivatives for the treatment of hyperglycaemia
05/06/1999CA2847985A1 Process for stereoselective synthesis of prostacyclin derivatives
05/06/1999CA2658884A1 Metal/thiol biocides
05/06/1999CA2568251A1 Process for preparing substituted 7-bromoquinolone-carboxylic acid derivatives
05/06/1999CA2309135A1 N,n-diethylglycolamido ester prodrugs of indole spla2 inhibitors
05/06/1999CA2308454A1 Antagonists of gonadotropin releasing hormone
05/06/1999CA2308453A1 Method of reducing craving in mammals
05/06/1999CA2308443A1 Morpholino-n-ethyl ester prodrugs of indole spla2 inhibitors
05/06/1999CA2308327A1 Sarcodictyin and eleutherobin useful for stabilising microtubules
05/06/1999CA2308070A1 Prevention of precipitated acute urinary retention
05/06/1999CA2308069A1 Antagonists of gonadotropin releasing hormone
05/06/1999CA2307952A1 4, 5-diaryloxazole compounds
1 ... 6504 6505 6506 6507 6508 6509 6510 6511 6512 6513 6514 6515 6516 6517 6518 6519 6520 6521 6522 6523 6524 ... 7860